Related Experiment Video
Updated: Aug 3, 2026

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Proproten-100 in the therapy of patients with the alcohol withdrawal syndrome
A G Gofman1, I N Pyatnitskaya, Yu V Valentik
1Moscow Institute of Psychiatry, Russian Ministry of Health.
Abstract:
The efficiency of Proproten-100 containing antibodies to S100 protein in ultralow doses and used to relieve somatovegetative and psychoneurological manifestations of the alcohol withdrawal syndrome was studied in a double-blind, placebo-controlled clinical trial. The preparation possessed anxiolytic, sedative, hypnagogic, and vegetostabilizing properties. Proproten-100 more rapidly relieved the alcohol withdrawal syndrome than standard drugs (by 2 times). Proproten-100 may used in combination with detoxicating and symptomatic drugs to treat patients with severe disorders. The preparation did not cause side effects. Our observations indicate that Proproten-100 may be used alone (monotherapy) or in combination with standard pharmaceutics for treatment of patients with the alcohol withdrawal syndrome.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Psychosis: Goals of Pharmacotherapy
Alzheimer's Disease: Treatment
Pharmaceutical Poisoning: Treatment Strategies
Drug Therapy
Antianxiety Medications

